Ocular Therapeutix, Inc. Common Stock (NASDAQ: OCUL) last traded at $11.08, down 0.09% on the session. The quote above updates while this page is open; the figures below are drawn from Ocular Therapeutix, Inc. Common Stock’s own filings and are restated only when a new one is published.
Ocular Therapeutix, Inc. Common Stock trades on NASDAQ under the ticker OCUL. Its market capitalisation is $2.43 billion.
Valuation measures for Ocular Therapeutix, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.43B |
|---|---|
| Enterprise value | $1.99B |
| Price / sales | 46.75 |
| Price / book | 4.68 |
| Beta | 0.98 |
Trailing-twelve-month figures tagged in Ocular Therapeutix, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $52.05M |
|---|---|
| Net income (TTM) | -$301.45M |
| EPS (TTM) | -$1.40 |
| Operating margin | -603.04% |
| Return on equity | -57.97% |
| Cash | $598.64M |
Range and volume for OCUL over the past 52 weeks.
| 52-week high | $16.44 |
|---|---|
| 52-week low | $6.23 |
| Volume | 3.02M |
| Average volume | 2.72M |
| Previous close | $11.09 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.